»Ê¹Ú²ÊƱ
Back to
Dr Anusha Hettiaratchi

Dr Anusha Hettiaratchi

Manager
Research & Enterprise
Bio Resources Imaging Lab
Mobile
0402906050
Phone
+61-2-9065 5665
E-mail
anusha@unsw.edu.au
  • Journal articles | 2023
    2023, 'Priorities in Biobanking Research: A Report on the 2021 ISBER Round Table', Biopreservation and Biobanking, 21, pp. 111 - 113,
    Journal articles | 2022
    2022, 'Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes', Clinical Cancer Research, 28, pp. 5383 - 5395,
    Journal articles | 2022
    2022, 'ISBER 2022 Annual Meeting: Biobanking—Shaping the Scientific Journey', Biopreservation and Biobanking, 20, pp. 469 - 470,
    Journal articles | 2022
    2022, 'MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma', Virchows Archiv, 480, pp. 855 - 871,
    Journal articles | 2021
    2021, 'Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability', Biomarker Insights, 16, pp. 1 - 10,
    Journal articles | 2015
    Scott GM; Hettiaratchi A; Salisbury E; Ward RL; Hawkins NJ, 2015, 'Institutional biobanking: An integral part of contemporary pathology practice', Pathology, 47, pp. 4 - 6,
    Journal articles | 2008
    Jackson NE; Wang HW; Bryant KJ; McNeil HP; Husain A; Liu K; Tedla N; Thomas PS; King GC; Hettiaratchi A; Cairns J; Hunt JE, 2008, 'Alternate mRNA splicing in multiple human tryptase genes is predicted to regulate tetramer formation.', The Journal of Biological Chemistry, 283, pp. 34178 - 34187,
    Journal articles | 2008
    2008, 'Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma', Clin Exp Allergy, 38, pp. 847 - 856,
    Journal articles | 2007
    2007, 'The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer', British Journal of Cancer, 96, pp. 783 - 792,
    Journal articles | 2005
    Jagger E; Hettiaratchi A; Carol H; Cameron B; Vollmer-Conna U; Davenport T; Hickie I; Wakefield D; Lloyd A, 2005, 'Polymorphisms in the interleukin-10 gene are associated with duration of illness following primary Epstein-Barr virus infection', Tissue Antigens, 66, pp. 452 - 453,
    Journal articles | 2002
    2002, 'Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivo.', Endocrinology, 143, pp. 4287 - 4294,
    Journal articles | 1998
    1998, 'Complete nucleotide sequence of pSK41: evolution of staphylococcal conjugative multiresistance plasmids.', J Bacteriol, 180, pp. 4350 - 4359,
    Journal articles | 1995
    1995, 'Multidrug resistance plasmid pSK108 from coagulase-negative staphylococci; relationships to Staphylococcus aureus qacC plasmids.', Plasmid, 34, pp. 62 - 67,
  • Other | 2023
    2023, Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, ,
    Other | 2023
    2023, Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, ,
    Other | 2023
    2023, Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, ,
    Other | 2023
    2023, Supplementary Figures S1-S13 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, ,
    Other | 2023
    2023, Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, ,
    Other | 2023
    2023, Supplementary Methods 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, ,
    Other | 2023
    2023, Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, ,
    Other | 2023
    2023, Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes, ,
    Conference Abstracts | 2014
    Meagher NS; Scott G; Hettiaratchi A; Schwensen J; Jonnagaddala J; Caruso L; Ward RL; Crowe P; Salisbury E; Liauw W; others , 2014, 'Two years, fifteen hundred consents and counting. Integrating the HSA Biobank within routine clinical practice within the SESLHD.', in Innovations in Cancer Treatment and Care, Sydney, Australia, 17 October 2014.
    Conference Presentations | 2001
    Hunt JE; Jackson N; Wang HW; Geczy C; Collins A; Hettiaratchi A; McNeil P, 2001, 'Murine bone-marrow derived mast cells migrate in response to IL-15', Vol. 15, pp. A355 - A355,
    Conference Presentations | 2000
    Wang HW; McNeil HP; Thomas PS; Murphy B; Webster MJ; Hettiaratchi A; King G; Heywood G; Huang C; Hunt JE, 2000, 'Molecular cloning and characterisation of novel human tryptase cDNAs and splice variants', Vol. 14, pp. A1239 - A1239,